EIGER BIOPHARMACEUTICALS INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EIGRQ and buy or sell other stocks, ETFs, and their options commission-free!About EIGRQ
Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia.
CEODavid Apelian, MD, PhD
CEODavid Apelian, MD, PhD
Employees—
Employees—
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2008
Founded2008
Employees—
Employees—
EIGRQ Key Statistics
Market cap12.59M
Market cap12.59M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume507.40
Average volume507.40
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.00
52 Week high$16.00
52 Week low$1.10
52 Week low$1.10
Stock Snapshot
The current EIGER BIOPHARMACEUTICALS INC(EIGRQ) stock price is $8.50, with a market capitalization of 12.59M. The stock trades at a price-to-earnings (P/E) ratio of -0.17.
On 2025-12-09, EIGER BIOPHARMACEUTICALS INC(EIGRQ) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for EIGER BIOPHARMACEUTICALS INC(EIGRQ) stock has reached 0, versus its average volume of 507.4.
Over the past 52 weeks, EIGER BIOPHARMACEUTICALS INC(EIGRQ) stock has traded between a high of $16.00 and a low of $1.10.
Over the past 52 weeks, EIGER BIOPHARMACEUTICALS INC(EIGRQ) stock has traded between a high of $16.00 and a low of $1.10.
People also own
Based on the portfolios of people who own EIGRQ. This list is generated using Robinhood data, and it’s not a recommendation.